Willow Health is a telehealth company that markets compounded drugs to patients and physicians nationally. Willow Health’s compounded semaglutide product line includes two products: “Semaglutide ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

Rybelsus ® (semaglutide) tablets 7 mg or 14 mg, the only FDA-approved oral GLP-1 medicine available, now indicated to reduce the risk of major adverse cardiovascular events (MACE) such as CV death, ...

Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill. NVO's first-half 2025 results showed robust growth, driven by obesity ...

GLP-1 agonists like Ozempic are primarily used to treat type 2 diabetes. Its popularity has even influenced wholesale retailer Costco to sell Ozempic and Wegovy (another popular semaglutide) at its ...

For patients undergoing kidney dialysis, the use of GLP-1 receptor agonist semaglutide showed safety, with no significant increase in serious cardiovascular adverse events or mortality. The findings ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the weight loss and diabetes medication often sold under the brand names Ozempic ...

Patients lost 14% to 17% of body weight taking the daily pill The pill could offer an alternative to weekly injections of GLP-1 drugs WEDNESDAY, Sept. 24, 2025 (HealthDay News) — A pill form of the ...